COMP <GO>
HR vs BAC // RSI-14 & 200D SMA MOMENTUM
Healthcare Realty Trust Incorporated (NYSE) VS. Bank of America Corporation (NYSE) • 15-METRIC TALLY: HR 7
— BAC 6
▲ RSI-14 & 200D SMA MOMENTUM LEADER: HR
LAST: $18.49 (+1.99%) • MKT CAP: $6.21B
rsi-technicals
60.2
LAST: $50.01 (-2.21%) • MKT CAP: $357.61B
rsi-technicals
27.7
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HR VS. BAC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HR | BAC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -3.70% | 2.50% | -6.20 | BAC | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.2x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 7.34% | 2.10% | +5.24 | HR | /fcf-yield <GO> |
| Operating Margin | -60.00% | 32.90% | -92.90 | BAC | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 27.00% | -87.00 | BAC | /net-margins <GO> |
| Revenue Growth (YoY) | 47.30% | 6.80% | +40.50 | HR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 6.23% | 0.00% | +6.23 | HR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.25 | 0.45 | +0.80 | HR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | HR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 6.60% | +0.40 | BAC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 60.2 | 27.7 | +32.49 | HR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 0.90 | +0.12 | HR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 34.0x | 10.9x | +23.10 | BAC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.21B | $357.61B | -$351.40B | BAC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HR REV | BAC REV | HR GROSS % | BAC GROSS % | HR FCF | BAC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $28.2M | $113.10B | 44.0% | 44.0% | $455.8M | $7.52B |
| FY 2024 | $19.2M | $105.86B | 44.0% | 44.0% | $500.8M | -$13.57B |
| FY 2023 | $17.5M | $102.77B | 44.0% | 44.0% | $499.0M | $40.36B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HR // BETA 1.02
BAC // BETA 0.90